Skip to main content
. 2023 Aug 18;13:1155650. doi: 10.3389/fonc.2023.1155650

Table 3.

Clinical characteristics of male lung and bronchus cancer patients by occupation: Florida Cancer Data System (1981–2014).

Characteristics All patients Occupation
Non-firefighters Firefighters Firefighters
Career Volunteer
N Col% N Col% N Col% N Col% N Col%
All patients 210,541 100.0 209,780 100.0 761 100.0 604 100.0 157 100.0
SEER stage
Localized 34,078 16.2 33,959 16.2 119 15.6 99 16.4 20 12.7
Regional 49,236 23.4 49,011 23.4 225 29.6 182 30.1 43 27.4
Distant 98,403 46.7 98,045 46.7 358 47.0 274 45.4 84 53.5
Unknown 28,824 13.7 28,765 13.7 59 7.8 49 8.1 10 6.4
Surgery received
No 163,357 77.6 162,803 77.6 554 72.8 430 71.2 124 79.0
Yes 45,996 21.8 45,793 21.8 203 26.7 171 28.3 32 20.4
Unknown 1,188 0.6 1,184 0.6 <10 <10 <10
Radiation received
No 125,864 59.8 125,443 59.8 421 55.3 336 55.6 85 54.1
Yes 80,206 38.1 79,886 38.1 320 42.0 252 41.7 68 43.3
Unknown 4,471 2.1 4,451 2.1 20 2.6 16 2.6 <10
Chemotherapy received
No 134,619 63.9 134,224 64.0 395 51.9 321 53.1 74 47.1
Yes 70,387 33.4 70,051 33.4 336 44.2 263 43.5 73 46.5
Unknown 5,535 2.6 5,505 2.6 30 3.9 20 3.3 10 6.4
Histology
NSCLC 148,986 70.8 148,413 70.7 573 75.3 455 75.3 118 75.2
SCLC 29,621 14.1 29,511 14.1 110 14.5 85 14.1 25 15.9
Unspecified/unknown 31,934 15.2 31,856 15.2 78 10.2 64 10.6 14 8.9
Vital status
Alive/dead—other causes 42,209 20.0 42,013 20.0 196 25.8 157 26.0 39 24.8
Dead—primary diagnosis 168,332 80.0 167,767 80.0 565 74.2 447 74.0 118 75.2

All p-values for comparing firefighters vs. non-firefighters and also for comparing career firefighters vs. volunteer firefighters vs. non-firefighters are less than 0.05, i.e., statistically significant, except the following: Histology was not significant by occupation: firefighters vs. non-firefighters (p > 0.05); radiation and histology were not significant by occupation: career firefighters vs. volunteer firefighters vs. non-firefighters (p > 0.05). Vital status is based on incidence cases from 1981 to 2014 with passive follow-up up to 31 December 2019, where death was due to lung and bronchus cancer.

SEER, Surveillance, Epidemiology, and End Results (SEER) Program; NSCLC, non-small cell lung cancer; SCLC, small cell lung cancer; –, sample size less than 10 not reported due to confidentiality rules.